Abstract:Nucleic acid aptamers (Apt) are RNA or DNA fragments that can bind specifically to a target molecule or to a target substrate with great affinity, thus has attracted great attention for diagnosis and treatment of various malignant diseases. Two primary strategies reported for efficient incorporation of Apt into a nanocarrier include physical encapsulation via electrostatic interactions and chemical conjugation via covalent bonds. Generally, physical encapsulation offers an easier approach for Apt functionalization than covalent bonding that involves sophisticated chemical design as well as synthesis and purification procedures. However, the effect of Apt's incorporation strategies on the property and performance of Apt-functionalized nanocarriers, to our knowledge, remains unclear, which clearly hampers the biomedical applications and potential clinical translations of Apt-decorated delivery systems. To clarify this critical issue toward better performance of Apt for biomedical applications, an Apt moiety with a specific targeting property to liver cancer cells was introduced to a previously fabricated polymeric prodrug, chitosan-5-fluorouracil-1-acetic acid (CS-FU) via either an amide link or electrostatic interactions to afford two types of Apt-functionalized polymeric prodrugs, i.e., Apt/CS-FU and Apt-CS-FU with an equivalent amount of incorporated Apt, respectively. The in vivo and in vitro anti-tumor efficacy and targeting properties of these two Apt-functionalized polymeric prodrugs were investigated and further compared in detail. Interestingly, the two self-assembled micelles showed almost identical in vitro targeting and antitumor efficiency, but Apt-CS-FU mediated 1.5-fold greater tumor inhibition rate (TIR) than Apt/CS-FU in murine tumor models. The better performance of Apt-CS-FU than that of Apt/CS-FU was substantially attributed to the smaller size of Apt-CS-FU than that of Apt/CS-FU in the presence of serum for prolonged in vivo circulation. The first disclosed Apt incorporation strategy effects on the performance and property of Apt-decorated nanocarriers is believed to promote rational design and future clinical translations of Apt-functionalized nanoplatforms with greater therapeutic efficiency.

Supramolecularly Engineered Circular Bivalent Aptamer for Enhanced Functional Protein Delivery

A bispecific circular aptamer tethering a built-in universal molecular tag for functional protein delivery.

Engineering Circular Aptamer Assemblies with Tunable Selectivity to Cell Membrane Antigens in Vitro and in Vivo.

Circular Bivalent Aptamers Enable in Vivo Stability and Recognition.

Molecular assembly for high-performance bivalent nucleic acid inhibitor

Enzymatic interlocking aptamer-micelles for enhanced cellular internalization and nucleus-targeted cancer phototherapy

Functionalized Aptamer with an Antiparallel G-quadruplex: Structural Remodeling, Recognition Mechanism, and Diagnostic Applications Targeting CTGF.

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

Molecular Engineering‐Based Aptamer–Drug Conjugates with Accurate Tunability of Drug Ratios for Drug Combination Targeted Cancer Therapy

Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems

Aptamer-Based Targeted Delivery of Functional Nucleic Acids.

Supramolecular Container-Mediated Surface Engineering Approach for Regulating the Biological Targeting Effect of Nanoparticles

Evolution of a highly functional circular DNA aptamer in serum

In-vivo Polyvalent Aptamer@Protein Based Nanocarrier with Synergistic Charge Effect for High Drug Loading, High Nuclease Resistance, and High Receptor Accessibility

Dynamic Polymer Amphiphiles for Efficient Intracellular and In Vivo Protein Delivery

Programmable Circular Multispecific Aptamer-Drug Engager to Broadly Boost Antitumor Immunity

Advances In The Development Of Aptamer Drug Conjugates For Targeted Drug Delivery

Structure-guided Engineering of Aptamers to Enhanced Structural Stability and Application Performance in Alleviating Β-Lactoglobulin Allergenicity

Optimized aptamer functionalization for enhanced anticancer efficiency in vivo

Rationally Designed Multivalent Aptamers Targeting Cell Surface for Biomedical Applications